TNBI Stock Overview
Tanke Biosciences Corporation, through its subsidiary, Best Energy Monitoring LLC, engages in the energy monitoring business.
| Snowflake Score | |
|---|---|
| Valuation | 0/6 |
| Future Growth | 0/6 |
| Past Performance | 0/6 |
| Financial Health | 0/6 |
| Dividends | 0/6 |
Tanke Biosciences Corporation Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | US$0.061 |
| 52 Week High | US$0.20 |
| 52 Week Low | US$0.046 |
| Beta | 0.49 |
| 1 Month Change | -19.69% |
| 3 Month Change | -38.50% |
| 1 Year Change | n/a |
| 3 Year Change | -20.65% |
| 5 Year Change | 515.00% |
| Change since IPO | -93.91% |
Recent News & Updates
Recent updates
Shareholder Returns
| TNBI | US Commercial Services | US Market | |
|---|---|---|---|
| 7D | 0% | 2.4% | 1.0% |
| 1Y | n/a | 30.7% | 21.9% |
Return vs Industry: Insufficient data to determine how TNBI performed against the US Commercial Services industry.
Return vs Market: Insufficient data to determine how TNBI performed against the US Market.
Price Volatility
| TNBI volatility | |
|---|---|
| TNBI Average Weekly Movement | n/a |
| Commercial Services Industry Average Movement | 7.0% |
| Market Average Movement | 6.0% |
| 10% most volatile stocks in US Market | 16.8% |
| 10% least volatile stocks in US Market | 3.0% |
Stable Share Price: TNBI's share price has been volatile over the past 3 months.
Volatility Over Time: Insufficient data to determine TNBI's volatility change over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 1989 | n/a | Caren Currier | www.tankebiosciences.com |
Tanke Biosciences Corporation, through its subsidiary, Best Energy Monitoring LLC, engages in the energy monitoring business. The company monitors and analyses accurate, itemized, and real-time energy data. Its assets are utilized in the monitoring of energy consumption using internet of things (IoT), big data, and artificial intelligence for commercial buildings, such as food retail, quick service, multi-site commercial, education, manufacturing, and hotels.
Tanke Biosciences Corporation Fundamentals Summary
| TNBI fundamental statistics | |
|---|---|
| Market cap | US$1.30m |
| Earnings (TTM) | -US$98.15k |
| Revenue (TTM) | n/a |
0.0x
P/S Ratio-13.2x
P/E RatioIs TNBI overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| TNBI income statement (TTM) | |
|---|---|
| Revenue | US$0 |
| Cost of Revenue | US$0 |
| Gross Profit | US$0 |
| Other Expenses | US$98.15k |
| Earnings | -US$98.15k |
Last Reported Earnings
Dec 31, 2022
Next Earnings Date
n/a
| Earnings per share (EPS) | -0.0046 |
| Gross Margin | 0.00% |
| Net Profit Margin | 0.00% |
| Debt/Equity Ratio | -60.2% |
How did TNBI perform over the long term?
See historical performance and comparison